Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17583811 | 0.98 | BCHE (0.30) | BCHEACHE | |
| Iodide SCHEMBL28722276 | 0.98 | BCHE (0.30) | BCHEACHE | |
| Bromide SCHEMBL28959814 | 0.98 | BCHE (0.32) | BCHEACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL1524371 | 0.82 | GPR3 (0.40) | ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL16712014 | 0.81 | PTPN1 (0.33) | — | |
| SCHEMBL28365341 | 0.79 | — | — | |
| Trifluoroacetic Acid SCHEMBL4413284 | 0.79 | TDP1 (0.39) | — | |
| SCHEMBL2597596 | 0.77 | ACHE (0.39) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL28349197 | 0.76 | ACHE (0.32) | ACHE | |
| Bromide SCHEMBL28346046 | 0.76 | ACHE (0.43) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290346-A | Method for producing amide compound, and amide compound | 广荣化学株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-112703184-B | Method for producing amide compound, and amide compound | 广荣化学株式会社 | 2024-06-11 | — | — | CN | disclosed |
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-08-31 | — | — | US | disclosed |
| EP-4130018-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | Sumitomo Chemical Company, Limited (JP) | 2023-02-08 | — | — | EP | disclosed |
| EP-2872147-A2 | CHIRAL CONTROL | Wave Life Sciences Pte. Ltd. (SG) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014012081-A2 | CHIRAL CONTROL | ONTORII, INC. (US) | 2014-01-16 | — | — | WO | disclosed |
| US-20130284210-A1 | SOLID FORMULATIONS, THEIR PREPARATION AND USE | BASF SE (DE) | 2013-10-31 | — | — | US | disclosed |
| US-7863294-B2 | Heterocycle derivatives as histone deacetylase (HDAC) inhibitors | INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2011-01-04 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, PORCN | BCHE 2091/4885ACHE 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.